CCND1 and glioblastoma: Recently, we identified a class of small molecule inhibitors which blocks the ability of the ITAF hnRNP A1 from associating with both of the cyclin D1 and c-myc IRES RNAs leading to reduced translation of these determinants and resulting in mTOR inhibitor sensitivity of GBM cells [24].